Ebinç, S. Et Al. 2022. Factors influencing HER2 discordance in nonmetastatic breast cancer and the role of neoadjuvant therapy. Future Oncology , vol.18, no.30 , 3399-3408.

Ebinç, S., Oruç, Z., Sezgin, Y., Karhan, O. u., Bilen, E., Yerlikaya, H., ... Kalkan, Z.(2022). Factors influencing HER2 discordance in nonmetastatic breast cancer and the role of neoadjuvant therapy. Future Oncology , vol.18, no.30, 3399-3408.

Ebinç, Senar Et Al. "Factors influencing HER2 discordance in nonmetastatic breast cancer and the role of neoadjuvant therapy," Future Oncology , vol.18, no.30, 3399-3408, 2022

Ebinç, Senar Et Al. "Factors influencing HER2 discordance in nonmetastatic breast cancer and the role of neoadjuvant therapy." Future Oncology , vol.18, no.30, pp.3399-3408, 2022

Ebinç, S. Et Al. (2022) . "Factors influencing HER2 discordance in nonmetastatic breast cancer and the role of neoadjuvant therapy." Future Oncology , vol.18, no.30, pp.3399-3408.

@article{article, author={Senar Ebinç Et Al. }, title={Factors influencing HER2 discordance in nonmetastatic breast cancer and the role of neoadjuvant therapy}, journal={Future Oncology}, year=2022, pages={3399-3408} }